Literature DB >> 33545636

Distinct roles of LRP5 and LRP6 in Wnt signaling regulation in the retina.

Harminder D Singh1, Jian-Xing Ma2, Yusuke Takahashi3.   

Abstract

Dysregulation of Wnt signaling is implicated in multiple ocular disorders. The roles of Wnt co-receptors LRP5 and LRP6 in Wnt signaling regulation remain elusive, as most retinal cells express both of the co-receptors. To address this question, LRP5 and LRP6 were individually knocked-out in a human retinal pigment epithelium cell line using the CRISPR-Cas9 technology. Wnt signaling activity induced by various Wnt ligands was measured using wild-type and the KO cell lines. The results identified three groups of Wnt ligands based on their co-receptor specificity: 1) activation of Wnt signaling only through LRP6, 2) through both LRP5 and LRP6 and 3) predominantly through LRP5. These results indicate that LRP5 and LRP6 have differential roles in Wnt signaling regulation.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas9 technology; LRP5; LRP6; Ocular disorder; Wnt ligand; Wnt signaling

Mesh:

Substances:

Year:  2021        PMID: 33545636      PMCID: PMC7919854          DOI: 10.1016/j.bbrc.2021.01.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  35 in total

1.  An LDL-receptor-related protein mediates Wnt signalling in mice.

Authors:  K I Pinson; J Brennan; S Monkley; B J Avery; W C Skarnes
Journal:  Nature       Date:  2000-09-28       Impact factor: 49.962

2.  LDL-receptor-related protein 6 is a receptor for Dickkopf proteins.

Authors:  B Mao; W Wu; Y Li; D Hoppe; P Stannek; A Glinka; C Niehrs
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 3.  LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way.

Authors:  Xi He; Mikhail Semenov; Keiko Tamai; Xin Zeng
Journal:  Development       Date:  2004-04       Impact factor: 6.868

4.  Both LRP5 and LRP6 receptors are required to respond to physiological Wnt ligands in mammary epithelial cells and fibroblasts.

Authors:  Shruti Goel; Emily N Chin; Saja A Fakhraldeen; Scott M Berry; David J Beebe; Caroline M Alexander
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

Review 5.  Wnt/beta-catenin signaling: components, mechanisms, and diseases.

Authors:  Bryan T MacDonald; Keiko Tamai; Xi He
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

6.  ARPE-19, a human retinal pigment epithelial cell line with differentiated properties.

Authors:  K C Dunn; A E Aotaki-Keen; F R Putkey; L M Hjelmeland
Journal:  Exp Eye Res       Date:  1996-02       Impact factor: 3.467

7.  Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.

Authors:  X Zhang; J P Gaspard; D C Chung
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

Review 8.  Canonical Wnt signaling in diabetic retinopathy.

Authors:  Qian Chen; Jian-Xing Ma
Journal:  Vision Res       Date:  2017-06-02       Impact factor: 1.886

9.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.

Authors:  Masaki Kato; Millan S Patel; Regis Levasseur; Ivan Lobov; Benny H-J Chang; Donald A Glass; Christine Hartmann; Lan Li; Tae-Ho Hwang; Cory F Brayton; Richard A Lang; Gerard Karsenty; Lawrence Chan
Journal:  J Cell Biol       Date:  2002-04-15       Impact factor: 10.539

10.  Deletion of LRP5 in VLDLR knockout mice inhibits retinal neovascularization.

Authors:  Chun-hong Xia; Eric Lu; Jing Zeng; Xiaohua Gong
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

View more
  1 in total

1.  Soluble very low-density lipoprotein receptor (sVLDLR) inhibits fibrosis in neovascular age-related macular degeneration.

Authors:  Xiang Ma; Yusuke Takahashi; Wenjing Wu; Jianglei Chen; Marcus Dehdarani; Wentao Liang; Young-Hwa Shin; Siribhinya Benyajati; Jian-Xing Ma
Journal:  FASEB J       Date:  2021-12       Impact factor: 5.834

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.